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Activation of Dual Apoptotic Pathways in Human
Melanocytes and Protection by Survivin
Tong Liu1, Diana Biddle1, Adrianne N. Hanks1, Brook Brouha2, Hui Yan1, Ray M. Lee1,3,4,
Sancy A. Leachman1,2 and Douglas Grossman1,2,3
Apoptosis resistance in melanoma is a primary cause of treatment failure. Apoptotic pathways in melanocytes,
from which melanoma arises, are poorly characterized. Human melanocytes were susceptible to apoptosis
following exposure to UV radiation (UVB, 24–48 hours), 4-tert-butylphenol (4-TBP, 1–4 hours), and cisplatin
(24–48 hours). These responses were associated with Bid cleavage, caspase activation (caspases 3, 8, and 9),
mitochondrial depolarization and release of cytochrome c, Smac/DIABLO, and apoptosis-inducing factor (AIF),
but not endonuclease G. The apoptotic responses and AIF release were caspase-independent, as they were not
blocked by zVal-Ala-Asp(OMe)-fluoromethyl ketone (zVAD-fmk). While RNA interference-mediated knock-
down of AIF protected melanocytes against apoptosis induced by serum withdrawal, apoptotic responses to
UVB, cisplatin, and 4-TBP were not compromised by AIF knockdown, even in the presence of zVAD-fmk. Finally,
adenoviral-mediated expression of Survivin, an inhibitor of apoptosis expressed in melanoma but not
melanocytes, protected melanocytes against UVB-induced apoptosis. Survivin expression in melanocytes
partially blocked caspase activation and release of mitochondrial release of AIF, cytochrome c, and Smac
induced by UVB. These data indicate that multiple stimuli can activate both caspase-dependent and caspase-
independent apoptotic pathways in melanocytes, and that endogenous expression of Survivin in melanoma
may contribute to apoptosis resistance by multiple mechanisms.
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INTRODUCTION
Apoptosis plays a critical role in regulating epidermal
development and restraining carcinogenesis. Keratinocytes
are highly susceptible to apoptosis and their rapid turnover
maintains epidermal homeostasis and eliminates premalig-
nant cells (Raj et al., 2006). The keratinocyte apoptotic
program, activated in vivo by UV light and cytokines, includes
death receptor signaling (Takahashi et al., 2001), caspase
activation (Sitailo et al., 2002), and mitochondrial depolariza-
tion (Denning et al., 2002), and leads to caspase-dependent
cell death (Grossman et al., 2001a). By contrast, apoptosis in
melanocytes is poorly understood and the physiologic signals
that induce melanocyte apoptosis are unknown.
Unlike keratinocytes, melanocytes in vivo exhibit slow
turnover and limited proliferative capacity (Yaar and Gilchr-
est, 1991), and physiologic exposure to UVB stimulates
melanin production and proliferation rather than apoptosis
(Gilchrest et al., 1999). While cyclic involution of the hair
follicle during catagen involves massive keratinocyte apop-
tosis, melanocytes are spared (Botchkareva et al., 2001).
Their survival in vivo depends on the expression of Bcl-2, as
Bcl-2-deficient mice exhibit progressive hair graying and
ultimately become hypopigmented (Veis et al., 1993) as a
result of melanocyte apoptosis (Nishimura et al., 2005). In
normal nevi, melanocytes are not mitotically active and
spontaneous apoptosis cannot be detected (Florell et al.,
2002). Nevo-melanocytes demonstrate increased apoptosis
resistance compared to isolated melanocytes (Alanko et al.,
1999), and in melanoma, apoptosis resistance is associated
with metastasis (Glinsky et al., 1997) and is likely responsible
for treatment failures (Grossman and Altieri, 2001). In the
acquired condition of vitiligo, melanocytes are eliminated by
apoptosis resulting from immune attack (Huang et al., 2002).
In vitro, melanocyte cell death can be induced by UVB (Zhai
et al., 1996), growth factor withdrawal (Halaban et al., 1993),
IFN-b (Krasagakis et al., 1991), transforming growth factor-b
(Rodeck et al., 1994), and the tyrosine analog 4-tert-
butylphenol (4-TBP) (Le Poole et al., 1999). We previously
demonstrated that in addition to UVB and 4-TBP, melanocyte
apoptosis can be induced in vitro by multiple drugs, but high
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doses and prolonged incubation are required (Bowen et al.,
2003).
There has been limited investigation of apoptotic path-
ways and regulators in melanocytes, or the role of caspase
activation in these various responses. Zhang et al. (2000)
reported that melanocytes are resistant to death receptor
signaling by tumor necrosis factor-a, Fas ligand, and tumor
necrosis factor-related apoptosis-inducing factor, which they
attributed to lack of the expression of tumor necrosis factor-
related apoptosis-inducing factor R1–R4 receptors. Zhai et al.
(1996) demonstrated that nerve growth factor protects
melanocytes from UVB-induced apoptosis, and is associated
with the upregulation of Bcl-2. Kim et al. (2000) found
upregulation and redistribution of Bax in UVB-irradiated
melanocytes. Kadekaro et al. (2005) reported that a-melano-
cortin protects melanocytes from UVB-induced apoptosis
through the inositol triphosphate kinase-Akt pathway and by
increasing phosphorylation and expression of the micro-
phthalmia-related transcription factor, known to upregulate
Bcl-2 expression (McGill et al., 2002). The resistance to death
receptor activation and potential regulation by Bcl-2 and Bax
(Bivik et al., 2005) suggests that melanocytes primarily
employ intrinsic (mitochondrial) rather than extrinsic (cas-
pase-8-dependent) apoptotic pathways. Consistent with this
notion, our survey of apoptotic regulatory proteins in
melanocytes found high expression of the primary regulators
of the intrinsic pathway, namely inhibitor of apoptosis (IAP)
and Bcl-2 family proteins, and the absence of the extrinsic
pathway regulator FLICE inhibitor protein (Bowen et al.,
2003). The only known apoptotic regulator expressed in
melanoma and nevi but not melanocytes appears to be the
inhibitor of apoptosis protein Survivin (Bowen et al., 2003).
Survivin may confer apoptotic protection in cancer cells by
multiple mechanisms, including caspase inhibition similar to
other inhibitor of apoptosis (Altieri, 2003). In a recent study,
we found that in addition to caspase activation, Survivin
inhibition in melanoma cells triggered translocation of
mitochondrial apoptosis-inducing factor (AIF) (Liu et al.,
2004), previously characterized as the primary mediator of
caspase-independent apoptosis (Susin et al., 1999).
In the present study, we demonstrate that in human
melanocytes multiple stimuli can trigger both caspase-
dependent and caspase-independent apoptosis associated
with caspase activation and mitochondrial AIF translocation,
respectively. Forced expression of Survivin in melanocytes
confers apoptotic protection, suggesting its potential con-
tribution to apoptosis resistance in nevi and melanoma.
RESULTS
Kinetics of melanocyte apoptosis
In previous studies, human melanocytes were stimulated with
UVB and a panel of drugs to determine optimal conditions of
apoptosis induction for each agent (Bowen et al., 2003).
Examination of the melanocyte cultures by light microscopy
revealed a difference between these stimuli that was not
appreciated in our initial examination of late-stage apoptosis.
We noted that 4-TBP had a dramatic and rapid effect,
inducing cell rounding and detachment within 1 hour of
exposure, whereas cells treated with UVB, cisplatin, or
staurosporine did not become detached until 24–48 hours
following exposure (not shown). This difference in kinetics of
cell detachment induced by 4-TBP compared to other agents
was recapitulated in our analysis of phosphatidylserine
externalization as an indicator of early-stage apoptosis. Cells
treated with 4-TBP uniformly exhibited Annexin binding at
1 hour, with increased binding at 4 hours (Figure 1). A
subpopulation of cells treated with UVB and cisplatin was
Annexinþ at 24 hours, with most of the remaining cells
becoming positive by 48 hours (Figure 1). The kinetics of
these responses are also shown (Figure 1, right panels). These
experiments established relevant time frames for further
investigation of melanocyte apoptotic pathways.
We observed concomitant activation of the effector
caspase-3 in response to all three stimuli, as indicated by a
decrease in the 32-kDa precursor and appearance of 20- and
17-kDa cleavage fragments. Caspase-3 cleavage fragments
were evident by 24–48 hours in both UVB- and cisplatin-
treated cells, and at 1 hour in 4-TBP-treated cells (Figure 2a).
We next evaluated upstream caspases representing extrinsic
(caspase-8) and intrinsic (caspase-9) apoptotic pathways.
Activation of the initiator caspase-8, reflected by a decreased
level of the 55-kDa precursor and appearance of the 35-kDa
cleavage fragment, was not prominent in cells treated with
4-TBP or cisplatin, but was evident by 48 hours in UVB-treated
cells (Figure 2a). Although the 35-kDa fragment was not seen
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Figure 1. Kinetics of melanocyte apoptosis. Melanocytes were untreated
(control, filled histogram) or exposed to 1,200 J/m2 UVB, 0.9 mM 4-TBP, or
90mM cisplatin (CP) for the indicated times. Cells were stained with
Annexin-PE and analyzed by flow cytometry. Shift to the right (left panels)
indicates increased red (FL2) fluorescence and Annexin positivity. Kinetics
of phosphatidylserine externalization are also shown (right panels).
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in response to 4-TBP or cisplatin, slight reduction of the
55-kDa precursor suggests some level of caspase-8 activation
occurs in response to these agents. Indeed, all three agents
resulted in the cleavage of Bid, known to be mediated by
activated caspase-8 (Green, 1998), as indicated by disap-
pearance of the 23-kDa precursor (Figure 2a). Activation of
the initiator caspase-9, as indicated by a decrease in the
45-kDa precursor and appearance of the 37-kDa cleavage
fragment, was prominently seen in both UVB- and cisplatin-
treated cells at 24–48 hours and in 4-TBP-treated cells at
1–4 hours (Figure 2a). The ability of all three agents to induce
Bid cleavage suggested, as noted above, that caspase-8 was
activated but in our hands Western blotting is a relatively
insensitive technique for detecting caspase-8 activation. We
therefore employed a more sensitive enzymatic assay to
confirm activation of caspase-8 by directly assaying cell
lysates using specific fluorogenic caspase substrates. As
shown in Figure 2b, activated caspase-3 and -8 were readily
detected following treatment with each apoptotic stimulus.
Thus, all three agents were capable of activating upstream
caspases and caspases representing both extrinsic and
intrinsic apoptotic pathways.
Mitochondria may either initiate or amplify caspase-
dependent apoptosis, depending on the experimental context
(Arnoult et al., 2002). We thus examined the kinetics of
mitochondrial depolarization in melanocytes treated with
UVB, 4-TBP, and cisplatin by monitoring changes in mito-
chondrial transmembrane potential. As shown in Figure 3,
responses to all three agents were characterized by a
time-dependent left-shift in JC-1 fluorescence, corresponding
to loss in transmembrane potential. Mitochondrial depolar-
ization proceeded gradually over 24–48 hours in UVB- and
cisplatin-treated cells and was complete by 1 hour in cells
treated with 4-TBP (Figure 3). The kinetics of these responses
are also shown (Figure 3, right panels). We next investigated
whether this mitochondrial depolarization was temporally
associated with the release of proapoptotic factors. Melano-
cytes were treated with UVB, 4-TBP, and cisplatin, and then
fractionated into mitochondrial and cytosolic components for
Western blotting. Cytochrome c, Smac/DIABLO, and AIF
were released into the cytosol in response to all three
apoptotic stimuli in the same time frame as mitochondrial
depolarization (Figure 4a). In contrast, none of these stimuli
resulted in release of endonuclease G (EndoG) (Figure 4a), a
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Figure 2. Caspase activation following apoptotic stimulation in melano-
cytes. (a) Melanocytes were treated with 1,200 J/m2 UVB, 0.9 mM 4-TBP, or
90mM cisplatin (CP) for the indicated times. Cell lysates (100 mg protein) were
then subjected to Western blotting for caspase-3, caspase-8, Bid, and caspase-
9 as indicated. Blotting for actin served as a loading control. Markers indicate
caspase-3 precursor (32 kDa) and cleavage fragments (20, 17 kDa), caspase-8
precursor (55 kDa) and cleavage fragment (35 kDa, asterisk), Bid 23 kDa
precursor, and caspase-9 precursor (45 kDa) and cleavage fragment (37 kDa).
Cleaved Bid fragment (tBid) is unstable and was not visualized. (b)
Melanocytes were untreated (control) or treated with 1,200 J/m2 UVB
(24 hours), 0.9 mM 4-TBP (30 minutes), or 90 mM cisplatin (CP, 24 hours) as
indicated. Cell lysates were assayed for activated caspase activity using
fluorogenic substrates for activated caspase-3 (open bars) or activated
caspase-8 (shaded bars). Induction of significant activity for each treatment
compared to control is indicated by asterisks (*Po0.001; **Po0.0001).
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Figure 3. Mitochondrial depolarization. Melanocytes were untreated
(control, filled histogram) or treated with 1,200 J/m2 UVB, 0.9 mM 4-TBP, or
90mM cisplatin (CP), and then stained with JC-1 at the indicated times (dotted
and solid line histograms) and analyzed by flow cytometry. Shift to the left
indicates decreased red (FL2) fluorescence (left panels). Kinetics of loss of
mitochondrial transmembrane potential (MTP) are also shown (right panels).
All values are normalized to mean JC-1 fluorescence in untreated cells.
www.jidonline.org 2249
T Liu et al.
Apoptotic Pathways in Human Melanocytes
mitochondrial protein that like AIF (Susin et al., 1999) can
translocate to the nucleus and mediate caspase-independent
apoptosis (Li et al., 2001). By fluorescence microscopy, we
confirmed that AIF was translocated to the nucleus in
apoptotic melanocytes treated with UVB, 4-TBP, and
cisplatin (Figure 4b), whereas neither cytochrome c (Figure
4c) nor EndoG (Figure 4d) exhibited nuclear translocation
under similar conditions.
Caspase-dependent and -independent apoptosis
Given the capacity of these apoptotic stimuli to induce AIF
translocation, we asked whether the apoptotic responses
were caspase-independent. Melanocyte responses to UVB,
4-TBP, and cisplatin were assessed in the presence of zVal-Ala-
Asp(OMe)-fluoromethyl ketone (zVAD-fmk), a pancaspase
inhibitor. In response to all these agents, apoptosis proceeded
despite the addition of zVAD-fmk (Figure 5a). To confirm that
induced terminal caspase activation was blocked by zVAD-
fmk under these experimental conditions, caspase activity
was measured directly in lysates prepared from melanocytes
treated at various time points in the absence or presence of
zVAD-fmk. Addition of zVAD-fmk was sufficient to block the
generation of terminal caspase-3 activity in cells treated with
UVB and cisplatin (Figure 5b) and 4-TBP (not shown). Next,
we examined whether AIF translocation was independent of
caspase activation by stimulating cells with UVB and 4-TBP
in the presence of zVAD-fmk. As shown in Figure 5c, AIF
release in UVB-, 4-TBP-, and cisplatin-treated melanocytes
was not inhibited by the addition of zVAD-fmk, indicating its
lack of dependence on caspase activation. Taken together,
these findings suggest that apoptotic stimulation in melano-
cytes independently activates both a caspase cascade and a
mitochondrial response that includes AIF translocation.
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Figure 4. Mitochondrial content release in apoptotic melanocytes.
(a) Melanocytes were treated with 1,200 J/m2 UVB, 0.9 mM 4-TBP, or 90 mM
cisplatin (CP) for the indicated times. Cells were then fractionated into
mitochondrial (M) and cytosolic (C) components, and electrophoresed and
blotted for cytochrome c, Smac/DIABLO, AIF, and EndoG as indicated. Blots
for voltage-dependent anion channel and actin confirm equivalent loading
among mitochondrial and cytosolic lysates, respectively. Amount loaded per
lane of mitochondrial and cytosolic lysates was 20 and 50mg, respectively.
(b) Melanocytes were untreated (control), or treated with 1,200 J/m2 UVB
(24 hours), 0.9 mM 4-TBP (1 hour), or 90 mM cisplatin (CP, 24 hours) as
indicated. Cells were then stained with anti-AIF (red) and 4,6-diamidino-2-
phenylindole (blue), and images were overlaid as shown. Purple color
indicates co-localization of AIF and nucleus. (c) Melanocytes were prepared
as in (b), and stained with anti-cytochrome c (red) and 4,6-diamidino-2-
phenylindole (blue), and images were overlaid as shown. Similar blue color of
nuclei in 4,6-diamidino-2-phenylindole and overlay panels indicates the
absence of cytochrome c in the nucleus. (d) Melanocytes were prepared as in
(b), and stained with anti-EndoG (red) and 4,6-diamidino-2-phenylindole
(blue), and images were overlaid as shown. Similar blue color of nuclei in
4,6-diamidino-2-phenylindole and overlay panels indicates the absence of
EndoG in the nucleus.
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Figure 5. Melanocyte apoptotic responses are caspase-independent.
(a) Melanocytes were treated with 1,200 J/m2 UVB (48 hours), 0.9 mM 4-TBP
(24 hours), or 90mM cisplatin (CP, 48 hours) in the absence (solid bars) or
presence (open bars) of 20 mM zVAD-fmk. Percent apoptotic cells was then
determined from the sub-G1 fraction obtained by flow cytometry of
propidium iodide-stained cells. Error bars reflect SEM from three independent
experiments. P-values for responses in the presence and absence of zVAD-
fmk were not significant (UVB, P¼ 0.59; 4-TBP, P¼0.25; CP, P¼0.82).
(b) Caspase-3 activity in apoptotic melanocytes is blocked by zVAD-fmk.
Melanocytes were untreated (solid bars) or treated with 1,200 J/m2 UVB (left
panel) or 90 mM cisplatin (CP, right panel) in the absence (shaded bars) or
presence of 20mM zVAD-fmk (open bars) for 24 or 48 hours as indicated.
Whole-cell lysates prepared at each time point were assayed for caspase-3
activity. Error bars reflect SEM from three measurements. Significant P-values
for caspase inhibition indicated by asterisks (*P¼ 0.03; **P¼0.003;
***Po0.001). (c) Caspase inhibition does not block AIF release. Melanocytes
were treated with 1,200 J/m2 UVB, 0.9 mM 4-TBP, or 90 mM cisplatin (CP) as
indicated in the absence or presence of 20 mM zVAD-fmk. Mitochondrial
(M, 20mg) and cytosolic (C, 50 mg) lysates were electrophoresed and blotted
for AIF and actin.
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Finally, we attempted to assess the contribution of the
caspase-independent component of the melanocyte apopto-
tic response by knocking down AIF. We screened small
interfering RNAs (siRNAs) directed against AIF, and were able
to achieve approximately 70% reduction of AIF levels
compared to untransfected cells or cells transfected with
control siRNA (Figure 6a). Under these conditions of AIF
knockdown, apoptotic responses to UVB were not appreci-
ably affected compared to untransfected cells (Figure 6b). In
addition, apoptotic responses of AIF-depleted cells were not
significantly altered in the presence of zVAD-fmk (Figure 6b).
Similar results were obtained for responses to cisplatin (Figure
6c) and 4-TBP (not shown). We considered the possibility that
the residual AIF was sufficient to mediate caspase-indepen-
dent apoptosis; however, our experimental conditions of AIF
knockdown in the presence of zVAD-fmk were sufficient to
protect melanocytes against apoptosis induced by serum
withdrawal (Figure 6d) – an apoptotic response shown in
other cell types to be dependent on AIF (Joza et al., 2001).
Thus, the susceptibility of AIF-depleted melanocytes to
UVB- and drug-induced apoptosis in the presence of zVAD-
fmk raises the possibility that an additional mediator of
caspase-independent apoptosis distinct from AIF (and EndoG)
may be involved in these responses.
Survivin confers apoptotic protection
The expression of Survivin in melanoma but not normal
melanocytes, and its capacity to protect against melanoma
cell apoptosis (Grossman et al., 1999, 2001b), suggested that
the acquisition of Survivin expression in melanocytes may
contribute to apoptosis resistance in nevi and melanoma. We
thus investigated whether forced expression of Survivin in
melanocytes could protect against these apoptotic pathways.
Melanocytes, which did not express Survivin, expressed high
levels of wild-type and mutant Survivin protein following
infection with adenoviruses expressing wild-type Survivin
(pAd-Surv) or a dominant-negative Survivin mutant (pAd-
T34A) (Figure 7a). Melanocytes were infected with one of
these adenoviruses or a control adenovirus (pAd- green
fluorescence protein (GFP)), treated with UVB, and then
apoptosis was assessed by flow cytometry. Whereas UVB
treatment resulted in marked apoptosis in melanocytes
infected with either pAd-GFP or pAd-T34A, there was not a
significant difference between untreated and UVB-treated
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Figure 6. AIF knockdown does not protect against apoptosis. (a) Knockdown of AIF by RNAi. Melanocytes were unmanipulated () or transfected with control
siRNA (Con) or siRNA targeting AIF (AIF). After 48 hours, whole-cell lysates were blotted for AIF and actin. Numbers below AIF blot indicate relative
densitometry readings, with untransfected cells set at 1. (b) Unmanipulated melanocytes (no RNAi) or melanocytes transfected with control siRNA (Con-RNAi)
or siRNA targeting AIF (AIF-RNAi) were untreated, or treated with UVB (48 hours) in the absence or presence of zVAD-fmk as indicated. Apoptotic cells were
assessed by flow cytometry as in Figure 5a. In each histogram, the bar indicates the percentage of apoptotic cells (sub-G1 fraction). Experiment is representative
of three performed in which significant AIF knockdown was achieved. (c) Melanocytes transfected with Con-RNAi or AIF-RNAi were untreated, or treated with
cisplatin (CP, 48 hours) in the absence or presence of zVAD-fmk as indicated. Apoptotic cells were assessed as in (b). Experiment is representative of two
performed in which significant AIF knockdown was achieved. (d) Melanocytes were transfected with Con-RNAi or AIF-RNAi, then 8 hours later were incubated
in normal medium or medium without serum (ser. WD) in the absence or presence of zVAD-fmk as indicated. After 48 hours, zVAD-fmk was re-added to
appropriate wells. Apoptotic cells were assessed as in (b) 96 hours after transfection. Experiment shown is representative of two performed in which significant
AIF knockdown was achieved.
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pAd-Surv-infected cells (P¼0.39) indicating Survivin-mediated
protection against UVB-induced apoptosis (Figure 7b).
The ability of exogenous Survivin to protect against
melanocyte apoptosis suggests it may inhibit both caspase-
dependent and caspase-independent apoptotic pathways.
Next, we further investigated protection against apoptosis
by Survivin at a mechanistic level by examining its effect on
potential mediators of these two pathways. First, melanocytes
from multiple donors were infected with pAd-GFP or pAd-
Surv, and then assayed for terminal caspase activation
following UVB treatment. While control and pAd-GFP-
infected cells exhibited a significant increase in caspase
activity in response to UVB, pAd-Surv-infected cells revealed
only minimal UVB-induced caspase activation (Figure 8a).
The induction of caspase activation in pAd-Surv-infected
cells was significantly reduced from that in uninfected
(P¼0.007) and pAd-GFP-infected (P¼ 0.003) cells following
UVB treatment. Finally, we examined mitochondrial trans-
location of proapoptotic mediators in Survivin-expressing
melanocytes following UVB treatment. While translocation
of AIF from mitochondria to cytosol was similarly observed in
control and pAd-GFP-infected cells following UVB, cytosolic
AIF levels were reduced by greater than 50% in cells pre-
infected with pAd-Surv (Figure 8b). Mitochondrial transloca-
tion of cytochrome c and Smac was similarly reduced in cells
infected with pAd-Surv compared to those infected with pAd-
GFP (Figure 8b). These results indicate that the capacity of
Survivin to protect against melanocyte apoptosis likely relates
to its previously described capacities to inhibit caspases
(O’Connor et al., 2000) as well as suppress translocation of
mitochondrial AIF (Liu et al., 2004), cytochrome c, and Smac.
DISCUSSION
This study provides an initial characterization of the
apoptotic program in melanocytes. We found that diverse
apoptotic stimuli activate dual apoptotic pathways: one
mediated by caspases, and another that is caspase-indepen-
dent and associated with nuclear translocation of mitochon-
drial AIF. The expression in melanocytes of many inhibitors
of apoptosis (Bowen et al., 2003), and their relative resistance
to common apoptotic stimuli (Bowen et al., 2003), is
consistent with their specialized function and longevity in
the skin (Vancoillie et al., 1999). However, given the extreme
hazard that transformation of these cells represents in the
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Figure 7. Forced Survivin expression in melanocytes and apoptotic
protection. (a) Melanocytes were uninfected or infected for 48 hours with
GFP-adenovirus (pAd-GFP), virus expressing wild-type human Survivin
(pAd-Surv), or virus expressing Survivin-T34A mutant (pAd-T34A). Cells
infected with pAd-Surv, seen by fluorescence microscopy (left panel).
Whole-cell lysates prepared from infected cells were subjected to Western
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indicate induction of apoptosis in UVB-treated compared to untreated cells
(*P¼0.095; **P¼ 0.04). Apoptosis induction in UVB-treated versus untreated
pAd-Surv-infected cells was not significant (P¼ 0.39).
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Figure 8. Survivin expression in melanocytes reduced caspase activation and
AIF release. (a) Melanocytes were uninfected (control) or infected for 48 hours
with pAd-GFP or pAd-Surv as indicated. Cells were then untreated (open bars)
or treated with 1,200 J/m2 UVB (shaded bars), and 24 hours later, whole-cell
lysates were prepared and assayed for caspase-3 activity as in Figure 5b.
Asterisk indicates that the level of UVB-induced caspase activation in
pAd-Surv-infected cells is reduced from that in uninfected (P¼0.007) and
pAd-GFP-infected (P¼0.003) cells. Experiment shown is representative of
four out of five performed. (b) Melanocytes were uninfected (control)
or infected for 48 hours with pAd-GFP or pAd-Surv as indicated. Cells were
then untreated or treated with 1,200 J/m2 UVB as indicated, and 24 hours later
were fractionated into mitochondrial (M) and cytosolic (C) components and
subjected to Western blotting as in Figure 4a. Note that there is some
translocation of mitochondrial factors resulting from adenoviral infection, so
the relevant comparisons are between pAd-GFP- and pAd-Surv-infected cells.
Densitometry values are indicated for cytosolic lanes comparing pAd-GFP
(arbitrarily set at 1) and pAd-Surv-infected cells treated with UVB. Experiment
shown is representative of two performed.
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development of melanoma, perhaps it is not surprising that
normal melanocytes are endowed with potentially redundant
apoptotic pathways. Forced expression of Survivin in
melanocytes conferred protection against both pathways.
Melanocytes were capable of generating a caspase
cascade in response to all the stimuli tested, consistently
revealing prominent activation of terminal caspase-3 and
initiator caspase-9, with minimal activation of initiator
caspase-8. The activation of terminal caspase-3 may originate
both from upstream caspase activation as well as mitochon-
drial release of factors known to enhance caspase-9 activa-
tion (cytochrome c) and relieve caspase inhibition (Smac/
DIABLO) (Reed, 2000). Our analysis of the kinetics of
apoptotic events indicated that caspase activation and
mitochondrial depolarization with content release occurred
concomitantly in response to a given stimulus, although these
responses to 4-TBP were much more rapid than those
induced by UVB or cisplatin. This tendency for greater
activation of intrinsic (caspase-9) versus extrinsic (caspase-8)
pathway-associated caspases is consistent with previous
reports implicating Bcl-2 family proteins in the regulation of
melanocyte apoptosis in vitro (Zhai et al., 1996; Kim et al.,
2000) and in vivo (Nishimura et al., 2005), and the lack of
death receptor signaling in melanocytes (Zhang et al., 2000).
Using a concentration of zVAD-fmk sufficient to neutralize
completely this caspase activity, we found that the addition of
zVAD-fmk did not prevent or reduce the apoptosis induced
by multiple stimuli, indicating that caspase activation was not
required for apoptosis induction. The resistance of these
apoptotic responses to zVAD-fmk was consistent with the
observed mitochondrial release and nuclear translocation of
AIF, previously characterized as the primary mediator of
caspase-independent apoptosis (Susin et al., 1999).
Several lines of evidence initially supported the notion that
caspases are not required for AIF-mediated (caspase-inde-
pendent) apoptosis. These included experiments demonstrat-
ing insensitivity to chemical caspase inhibitors such as
zVAD-fmk (Susin et al., 1999; Cregan et al., 2002; Yu
et al., 2002), and translocation and apoptosis induction
following microinjection of AIF into caspase-deficient cells
(Susin et al., 2000). However, a report by Zamzami et al.
(2000) of AIF release from purified mitochondria incubated
with activated caspases suggested the possibility that AIF
release could actually be triggered by caspase activation. In
addition, subsequent reports by Arnoult et al. (2002, 2003)
examining Bax-overexpressing 293 cells and HeLa cells
treated with staurosporine, actinomycin D, and hydrogen
peroxide found that AIF release could be blocked by zVAD-
fmk and occurred downstream of cytochrome c release.
These studies, taken together with one in Caenorhabditis
elegans demonstrating that WAH-1 (AIF) translocation
stimulated by the proapoptotic factor EGL-1 required the
caspase homolog CED-3 (Wang et al., 2002), suggested the
possibility in some cells of a retrograde pathway in which AIF
release depends upon caspase activation. Although such a
phenomenon may occur in certain cell types exposed to
particular apoptotic stimuli, our present finding that AIF
release occurred in the presence of zVAD-fmk suggest that in
melanocytes caspase activation is not required for AIF
release. Rather, various apoptotic stimuli appear to elicit
simultaneously distinct caspase-dependent and caspase-
independent apoptotic pathways in melanocytes.
In C. elegans, the AIF homolog (WAH-1) associates with
EndoG (CPS-6) and both are required to mediate DNA
degradation (Wang et al., 2002). Since we did not observe
co-translocation of EndoG with AIF from mitochondria in
apoptotic melanocytes, AIF appeared to be the sole mediator
of caspase-independent apoptosis in these cells. We at-
tempted to dissociate the caspase-dependent component of
the apoptotic response by AIF knockdown, which was
problematic given the resistance of normal melanocytes to
lipid-based transfection (T Liu and D Grossman, unpublished
observation). Gene suppression in normal human melano-
cytes using siRNA or antisense is impaired by the poor
transfectability of these cells. Nevertheless, we were able to
achieve 70% knockdown of AIF, but found that this level of
AIF depletion did not significantly affect melanocyte apopto-
tic responses even in the presence of zVAD-fmk. Our
experimental conditions for AIF knockdown coupled with
zVAD-fmk were, however, sufficient to protect melanocytes
against apoptosis induced by serum withdrawal. This
apoptotic response has been shown in other cell types to be
dependent on AIF (Joza et al., 2001). Thus, although it is
possible that the residual AIF was sufficient to mediate
caspase-independent apoptosis, our results suggest the
intriguing possibility that an alternate factor distinct from
AIF may be involved in these melanocyte apoptotic
responses.
Finally, these studies provide a rationale for the expression
of Survivin in melanoma. Survivin is notable among the many
known regulators of apoptosis for its selective expression in
cancer (Velculescu et al., 1999), and appears to be the only
one expressed in melanoma and nevi but not normal
melanocytes (Grossman et al., 1999; Bowen et al., 2003;
Florell et al., 2005). Survivin expression is a critical viability
factor in melanoma cells, as its inhibition results in
spontaneous apoptosis (Grossman et al., 1999, 2001b).
Through disabling apoptotic responsiveness in melanocytes,
Survivin expression may thereby promote nevus development
and transformation to melanoma. In an attempt to understand
its function in melanoma cells, we recently examined the
apoptotic events following expression of an inducible
Survivin antagonist. Apoptosis induced by Survivin targeting
was associated with caspase activation but resistant to zVAD-
fmk, and AIF translocation appeared to precede caspase
activation following Survivin inhibition (Liu et al., 2004).
These findings suggested to us that acquisition of Survivin
expression in melanoma cells may confer protection against
both caspase-dependent and caspase-independent apoptotic
pathways, and that the latter may involve suppression of AIF
release. The AIF pathway can be viewed as an accessory
apoptotic pathway enabling cells to remain apoptosis-
competent should caspase pathways fail – as known to occur
in melanoma (Grossman and Altieri, 2001) and other cancers
(Schimmer et al., 2003). Malignant cells thwart this ‘‘back-
up’’ function through the expression of Survivin. On the other
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hand, melanocytes, which do not express Survivin (Grossman
et al., 1999; Bowen et al., 2003), were shown here to be
highly susceptible to caspase-independent apoptosis. We
observed that forced expression of Survivin in melanocytes
conferred apoptotic protection and was associated with
reduced caspase activation and AIF translocation, supporting
the notion that it may protect both against caspase-dependent
and caspase-independent apoptosis as previously suggested
in other cell types (Shankar et al., 2001; Liu et al., 2004). The
protective capacity of Survivin, despite its inability to
suppress completely caspase activation and AIF release, is
consistent with the possibility of additional antiapoptotic
functions associated with its expression as suggested recently
(Fortugno et al., 2003).
MATERIALS AND METHODS
Drugs and chemicals
4-TBP (Aldrich, Milwaukee, WI) was prepared monthly in 70%
ethanol and stored at 201C. Cisplatin (Sigma Chemical Co, St
Louis, MO) was dissolved in dimethyl formamide and stored at 41C.
The pancaspase inhibitor zVAD-fmk was obtained from Enzyme
Systems Products (Livermore, CA), solubilized in DMSO, and stored
at 201C.
Antibodies
Purified rabbit polyclonal antibody recognizing Survivin has been
described previously (Grossman et al., 1999) and is commercially
available from NOVUS Biologicals (Littleton, CO). Rabbit polyclonal
antibodies against precursor and cleavage fragments of caspase-3
(sc-7148), caspase-8 (sc-7890), and caspase-9 (sc-7885) were
purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Rabbit
polyclonal antibody against cytochrome c (sc-7159), Smac/DIABLO,
and voltage-dependent anion channel were from Santa Cruz,
Imgenex (San Diego, CA), and Affinity BioReagents Inc. (Golden,
CO), respectively. Goat polyclonal antibodies against Bid (sc-6538)
and AIF (sc-9416) were also from Santa Cruz. Mouse mAb against
b-actin (clone AC-74) was obtained from Sigma. Rabbit polyclonal
antibody against EndoG was obtained from ProSci Inc. (Poway, CA).
Cells
Normal human melanocytes were obtained from discarded fore-
skins, in accordance with the Declaration of Helsinki Principles, and
as approved by the Institutional Review Board at the University of
Utah (no. 8476). Melanocytes were isolated and propagated in
Ham’s F10 containing 7.5% fetal bovine serum, 0.1 mM 3-isobutyl-1-
methylxanthine (Sigma), 1 mM sodium orthovanadate (Sigma), 2.5 nM
cholera toxin (Sigma), 50 ng/ml phorbol 12-myristate 13-acetate
(Sigma) and antibiotics as described previously (Bowen et al., 2003).
Second and third passage melanocytes were used for all experi-
ments.
Apoptosis induction and detection
Cells were exposed to UVB or drugs and recovered by trypsinization
(including non-adherents) as described previously (Bowen et al.,
2003). For serum withdrawal experiments, melanocytes were plated
in normal medium the day before, then washed and incubated with
medium lacking serum but containing other components. Late-stage
apoptosis was assessed by total cellular DNA content using
propidium iodide and flow cytometry as described previously
(Grossman et al., 1999). Activity of caspase-3 and -8 in cell lysates
was measured using the fluorogenic substrates Ac-DEVD-MCA and
Ac-IETD-MCA, respectively, according to the manufacturer’s in-
structions (Peptides International Inc., Louisville, KY). Early-stage
apoptosis was assessed by phosphatidylserine staining using an
Annexin V-PE kit (Santa Cruz), and mitochondrial depolarization
was assessed by JC-1 (Molecular Probes, Eugene, OR) fluorescence,
both as described previously (Liu et al., 2004).
Mitochondrial isolation
Trypsinized melanocytes were pooled from multiple dishes
(200–300 cm2), washed in cold phosphate-buffered saline, and
resuspended in mitochondrial isolation buffer (0.35 ml) consisting
of 0.3 M mannitol (Sigma), 70 mM sucrose, 1 mM EGTA, and 10 mM
HEPES (Calbiochem, La Jolla, CA). This solution was drawn into a
1 cm3 insulin syringe and forcefully passed through a 0.5-inch 28-G
needle 20 times and then transferred to a 1.5 ml microfuge tube.
After centrifugation (1,000 g) at 41C for 10 minutes, the super-
natant was collected and the pellet containing undisrupted cells and
nuclei was discarded. This supernatant was spun again (14,000 g)
at 41C for 15 minutes. The resulting supernatant (cytosolic fraction)
was collected, and the pellet was washed once in mitochondrial
isolation buffer and then resuspended in 80 ml mitochondrial
isolation buffer (mitochondrial fraction). Protein content in the
fractions was determined using the Protein Assay reagent (Bio-Rad
Laboratories, Hercules, CA). Fractions were diluted in SDS-contain-
ing sample buffer, aliquotted, and stored at 201C.
Western blotting
Cell lysates were prepared, electrophoresed, transferred to
PVDF membranes, and blocked with nonfat milk as described
previously (Grossman et al., 1999). Blots were incubated with
primary antibodies against Survivin (0.5 mg/ml), caspase-3 (1:400),
caspase-8 (1:200), caspase-9 (1:200), Bid (1:200), cytochrome c
(1:400), Smac/DIABLO (1mg/ml), voltage-dependent anion channel
(1:750), b-actin (1:30,000), AIF (1:250), or EndoG (1 mg/ml) for
1–2 hours at room temperature, then with species appropriate
horseradish peroxidase-conjugated Ig (New England Nuclear,
Boston, MA). Bands were visualized by enhanced chemilumines-
cence (Perkin-Elmer Life Sciences Inc., Boston, MA) and autoradio-
graphy.
Fluorescence microscopy
Cells were plated on coverslips, and following exposure to apoptotic
stimuli, were stained with anti-AIF antibody (Santa Cruz) as
described previously (Liu et al., 2004). Staining for cytochrome c
(1:200) and EndoG (15 mg/ml) was performed for 1 hour at 371C, then
after washing in phosphate-buffered saline, cells were stained with
Alexa Fluor-conjugated goat-anti-rabbit IgG (1:200, Molecular
Probes) for 1 hour at 371C. Coverslips were adhered to glass slides
using a mounting solution containing 4,6-diamidino-2-phenylindole
(Sigma) as described (Liu et al., 2004). Cells were visualized using a
Olympus IX70 fluorescence microscope, and images were obtained
with an Olympus Microfire camera and overlaid using Pictureframe
software (Optronics, Goleta, CA). Images were cropped, merged into
panels, and colors for each panel were simultaneously optimized in
Photoshop.
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RNA interference
The RNA oligos targeting nucleotides 151–171 in human AIF, 50-
CUUGUUCCAGCGAUGGCAUtt-30 (sense) and 50-AUGCCAUCG
CUGGAACAAGtt-30 (antisense), and control oligos 50-AGACAGAA
GACAGAUAGGCtt-30 (sense) and 50-GCCUAUCUGUCUUCUGU
CUtt-30 (antisense), were synthesized by our core facility. Each pair
of oligos was solubilized in RNA interference (RNAi) suspension
buffer (Qiagen, Valencia, CA) and mixed at a final concentration of
20 mM, heated at 901C for 1 minute, incubated at 371C for 1 hour to
anneal, and then stored at 201C. Oligos targeting other sequences
in AIF were also prepared, but found to be less effective in
preliminary experiments. We tested multiple additional parameters,
including cell density, siRNA and lipid concentration, and incuba-
tion times. In our optimized protocol, 2 105 cells were plated in
2 ml medium without antibiotics per well in six-well plates 1 day
prior to transfection. For each transfection, 2 ml of stock siRNA
duplex was added to 150 ml of OptiMEM medium (Life Technologies,
Rockville, MD) and 7ml of Lipofectamine2000 (Life Technologies)
was added to 150 ml of OptiMEM. After 5 minutes, the diluted siRNA
was combined with the diluted Lipofectamine2000 and the mixture
was incubated for 20 minutes at room temperature to allow
complexes to form. Complexes (309 ml) were added to cells
(70–80% confluency) in 1.5 ml antibiotic-free medium per well,
and plates were incubated at 371C in 5% CO2 incubator for
48 hours. For RNAi experiments involving serum withdrawal, serum
was removed from the medium 8 hours following transfection.
Adenoviral infection
The recombinant replication-defective GFP-expressing pAd adeno-
virus (control, pAd-GFP) expressing human wild-type Survivin (pAd-
Surv) and mutant Survivin-T34A (pAd-T34A) were kindly provided
by Dario Altieri (University of Massachusetts) and are described
elsewhere (Mesri et al., 2001). These viruses were propagated in 293
cells, purified, and titered as described (Mesri et al., 2001). Aliquots
were stored at 801C. Melanocytes seeded at 70% confluency into
35 mm dishes were infected by the addition of virus to the culture
medium. After 8 hours, the medium was aspirated and replaced with
fresh medium. Since all the viruses express GFP, infection could be
monitored by fluorescence microscopy of GFP-expressing cells. For
each experiment, each virus was used at an inoculation dose that
resulted in comparable percentages of GFP-expressing cells after 24
(40–50%) and 48 hours (80–90%).
Statistical analysis
Data derived from multiple determinations were subjected to
unpaired t-tests using Welch’s correction (Prism 3.0, Graphpad
software, San Diego, CA). Data from some experiments were
subjected to two-way analysis of variance analysis using Statistica
6.0 (StatSoft Inc., Tulsa, OK) to assess the significance of differences
between groups.
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